Seven Bridge Financial Group, LLC Orgenesis Inc. Transaction History

Seven Bridge Financial Group, LLC

  • $552 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 09, 2019
SELL
$4.18 - $4.85 $1,045 - $1,212
-250 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$5.0 - $14.68 $1,250 - $3,670
250 New
250 $3,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email